Life Sciences

Reduce risk and improve performance with behavioral intelligence

Existing data shows what happened. Surgo explains what drives action.

Claims, prescribing data, CRM activity, and SDOH can show utilization, outreach, and structural constraints.

Surgo adds the behavioral intelligence layer

that explains why patients engage, enroll, initiate, adhere, or drop off.

One intelligence layer across the life sciences lifecycle

Surgo’s products work together to help teams identify barriers earlier, tailor action more precisely, and improve performance across clinical trials, commercial, and medical affairs.

  • BehavioralPulse™

    Population-scale behavioral data that captures the attitudes, constraints, and contextual factors shaping health decisions.

  • Derin®

    An AI-powered intelligence layer for healthcare that captures lived experience and uncovers the drivers of health decisions.

  • Mosaic™ / MosaicTrials™

    Geographic and site-level intelligence to prioritize where action is needed and where performance is most at risk.

Clinical Trials

Reduce trial risk by understanding recruitability and retention, not just eligibility

Most trial teams know where eligible patients are. Surgo helps teams understand who is most likely to enroll, what barriers may get in the way, and which sites need different strategies to succeed.

What we are

A behavioral intelligence layer for clinical trials

What we are not

A patient-finding platform, site network, recruitment company, or outreach execution vendor

Use Cases

  • 01

    Prioritize sites by recruitability

    Go beyond incidence, prevalence, and historical performance to identify sites serving populations more likely to enroll and stay engaged.

  • 02

    Sharpen study startup

    Understand the trust, burden, access, literacy, and support barriers shaping site and patient performance before launch.

  • 03

    Tailor recruitment and retention strategies

    Adapt outreach, navigation, communication, and support to distinct behavioral profiles rather than using one-size-fits-all approaches.

  • 04

    Detect slowdown risk earlier

    Identify sites and populations at risk of underperforming before delays become costly rescue efforts.

Commercial

Improve initiation, onboarding, and persistence by understanding what gets in the way

Commercial teams have rich operational data but limited visibility into why patients hesitate, drop off, or never start.

Surgo explains the behavioral drivers behind those moments —

identifying where friction is highest, who is most likely to move forward, and what support actually helps.

Use Cases

  • 01

    Improve onboarding from the start

    Route patients into the right pathway based on trust, self-efficacy, literacy, digital comfort, and structural barriers.

  • 02

    Forecast affordability friction

    Identify patients likely to abandon at the cost or coverage step, before the prescription is lost.

  • 03

    Predict adherence and persistence risk

    Add behavioral drivers to existing models to identify who is most at risk and why.

  • 04

    Tailor communication more precisely

    Adapt outreach by readiness, trust, literacy, and channel receptivity, not just demographics.

Medical Affairs

Surface the patient, provider, and caregiver context behind real-world treatment decisions

Medical affairs teams are going proactive —

generating RWE, accelerating launch readiness, and closing care gaps in the market.

Surgo adds the behavioral signal that claims and CRM data don't capture:

what patients believe and the barriers they face, what HCPs misunderstand, and where caregivers shape the decision.

Use Cases

  • 01

    Equip MSLs with the patient context behind HCP decisions

    Give field teams behavioral intelligence on the patients their HCPs are treating — trust dynamics, affordability friction, structural barriers — so MSL conversations land where they matter.

  • 02

    Close knowledge gaps before they shape prescribing

    Identify the misconceptions, mechanism confusion, and information gaps driving how community HCPs and specialists prescribe — and where targeted education will move the needle.

  • 03

    Target launch where HCPs and patients are ready

    Sequence launch and educational investment by HCP readiness, patient access barriers, and local care gaps — not just historical Rx volume. and how they respond.

  • 04

    Generate RWE that explains why, not just what

    Add patient-reported cost and access barriers, caregiver burden, and HCP decision drivers to RWE strategy, advisory inputs, and publication planning.

+30%

lift in predicting high-performing sites

2x

faster budget development

1-day

diversity action plans

Experience across oncology, immunology, CNS, and vaccine studies

Why Surgo

Built to complement the data and systems life sciences teams already use

Surgo is not a replacement for claims, EHR, CRM, engagement platforms, or clinical systems. It is a behavioral intelligence layer designed to strengthen them — generating proprietary behavioral data, explaining why people act, and integrating into the workflows life sciences teams already run.

  • 260M+

    patient profiles in Surgo's proprietary behavioral intelligence layer

  • 10+

    years building behavioral data and AI products purpose-built for healthcare

  • 40+

    clients, including top pharma

Bring behavioral intelligence into your life sciences strategy

Whether you are improving trial feasibility, strengthening patient support, or generating deeper audience insight, Surgo helps teams act with greater precision.